About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Houston | 108 Studies

Clinical Trials Multiple SclerosisHouston

Multiple Sclerosis Clinical Trials in Houston

Find 108 clinical trials for multiple sclerosis near Houston, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 108 trials

UnknownLongitudinal Optic Neuritis Study (LONS)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000147·Little Rock, Arkansas and 14 others RecruitingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum…NCT03816345·Birmingham, Alabama and 51 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409Primary Objective: To evaluate long-term safety of alemtuzumab. Secondary Objectives: * To evaluate long term efficacy of alemtuzumab.NCT02255656·Cullman, Alabama and 130 others

UnknownMotor Skill Acquisition Between Individuals With Neurological Disorders and Healthy IndividualsStroke survivors frequently show persistent gait deficits in their chronic stages even after years of intensive rehabilitation.NCT04503187·Houston, Texas

Active not recruitingA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisThis is a Phase IIIb, single-arm, multicenter, OLE study.NCT05269004·Phoenix, Arizona and 231 others

CompletedA 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple SclerosisThe purpose of this study is to evaluate the change in patient-reported outcomes, physician assessment of a change as well as safety and tolerability in patients with Relapsing…NCT01216072·Birmingham, Alabama and 148 others

TerminatedStudy of Diroximel Fumarate in the Real-World SettingThe primary objective of the study is to characterize the persistence to therapy in participants with relapsing forms of multiple sclerosis (RMS) treated with diroximel fumarate…NCT04746976·West Hollywood, California and 17 others

CompletedA Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisThis randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in…NCT01247324·Phoenix, Arizona and 141 others

CompletedBEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsThe purpose of this study is to determine * whether treatment with Betaferon / Betaseron (interferon beta-1b) 500 micrograms safe, tolerable and more efficacious than treatment…NCT00099502·Birmingham, Alabama and 198 others

CompletedSafety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisThe objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 capsules in the treatment of central neuropathic pain in participants with…NCT01324232·Cullman, Alabama and 71 others

CompletedHigh-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) StudyThe purpose of this study is to determine the effectiveness of a new treatment for multiple sclerosis (MS), a serious disease in which the immune system attacks the brain and…NCT00288626·Columbus, Ohio and 3 others

CompletedLong Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisThe current study is a continuation of the 5 year extension study of the phase III CHAMPS study (see reference).NCT00179478·Derby, Connecticut and 25 others

TerminatedPhase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple SclerosisThe purpose of this study is to evaluate the safety and tolerability of ATA188 as a monotherapy in Parts 1 and 2, to determine the recommended Part 2 dose (RP2D) of ATA188 as…NCT03283826·La Jolla, California and 30 others

CompletedA Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple SclerosisThis was a Phase II, randomized, open-label, rater-blinded, three-arm study comparing two different doses of alemtuzumab (Lemtrada™) and one dose of subcutaneous (SC) interferon…NCT00050778·Scottsdale, Arizona and 48 others

TerminatedEfficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)The primary objective of Part 1 of this study is to evaluate the effects of BIIB033 versus placebo on disability improvement over 72 weeks.NCT03222973·Cullman, Alabama and 158 others

CompletedAutologous T Cell Vaccine (TCV) for Multiple SclerosisThis is a 1 year study to evaluate the efficacy, safety, and tolerability of Tovaxin T cell therapy in subjects with a clinically isolated syndrome (CIS) and relapse-remitting…NCT00245622·Cullman, Alabama and 32 others

CompletedA Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisThe purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).NCT03737851·Birmingham, Alabama and 48 others

RecruitingStudy to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabThe primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab in participants with relapsing multiple sclerosis (RMS) as measured by T1…NCT05877963·Birmingham, Alabama and 50 others

CompletedA Study of C105 on Cognitive Dysfunction in Persons With Multiple SclerosisThe purpose of this study is to determine the safety and efficacy of C105 in treating the cognitive deficits that can occur due to multiple sclerosis.NCT00529581·Phoenix, Arizona and 29 others

Active not recruitingDetermining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMSThe DELIVER-MS study seeks to answer the question: Does early treatment with highly effective DMT improve the prognosis for people with MS? This is an area of significant…NCT03535298·Aurora, Colorado and 29 others

PreviousPage 4 of 6Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia